DK0389286T3 - Rekombinant-cytomegalovirus-vaccine - Google Patents

Rekombinant-cytomegalovirus-vaccine

Info

Publication number
DK0389286T3
DK0389286T3 DK90303108.6T DK90303108T DK0389286T3 DK 0389286 T3 DK0389286 T3 DK 0389286T3 DK 90303108 T DK90303108 T DK 90303108T DK 0389286 T3 DK0389286 T3 DK 0389286T3
Authority
DK
Denmark
Prior art keywords
cytomegalovirus vaccine
recombinant cytomegalovirus
recombinant
vaccine
subunit
Prior art date
Application number
DK90303108.6T
Other languages
English (en)
Inventor
Stanley A Plotkin
Robert P Ricciardi
Eva Gonczol
Original Assignee
Wistar Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Inst filed Critical Wistar Inst
Application granted granted Critical
Publication of DK0389286T3 publication Critical patent/DK0389286T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK90303108.6T 1989-03-24 1990-03-22 Rekombinant-cytomegalovirus-vaccine DK0389286T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32840689A 1989-03-24 1989-03-24

Publications (1)

Publication Number Publication Date
DK0389286T3 true DK0389286T3 (da) 1996-11-18

Family

ID=23280848

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90303108.6T DK0389286T3 (da) 1989-03-24 1990-03-22 Rekombinant-cytomegalovirus-vaccine

Country Status (7)

Country Link
EP (1) EP0389286B1 (da)
AT (1) ATE140154T1 (da)
CA (1) CA2012895C (da)
DE (1) DE69027695T2 (da)
DK (1) DK0389286T3 (da)
ES (1) ES2091221T3 (da)
GR (1) GR3020765T3 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552143A (en) * 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
US5591439A (en) * 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
WO1994023744A1 (en) * 1993-04-16 1994-10-27 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
US5820868A (en) * 1993-12-09 1998-10-13 Veterinary Infectious Disease Organization Recombinant protein production in bovine adenovirus expression vector system
US6448389B1 (en) 1996-04-23 2002-09-10 The Wistar Institute Of Anatomy And Biology Human cytomegalovirus DNA constructs and uses therefor
EP0998576B1 (en) 1997-06-23 2007-10-31 The University of Saskatchewan Method for producing a recombinant bovine adenovirus vector
US6451319B1 (en) 1999-04-09 2002-09-17 Schering-Plough Veterinary Corporation Recombinant and mutant adenoviruses
JP2003534805A (ja) 2000-05-31 2003-11-25 ユニバーシティ オブ サスカチュワン 変化した親和性を有する改変ウシアデノウイルス

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689225A (en) * 1984-11-02 1987-08-25 Institut Merieux Vaccine for cytomegalovirus
CA1335429C (en) * 1986-03-07 1995-05-02 Geoffrey L. Smith Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor
DE3619720A1 (de) * 1986-06-12 1987-12-17 Behringwerke Ag Hauptglykoprotein des menschlichen cytomegalovirus, seine herstellung und verwendung
ATE82985T1 (de) * 1986-06-12 1992-12-15 Behringwerke Ag Strukturelles phosphoprotein (pp 150) des menschlichen cytomegalovirus, seine herstellung und verwendung.
DE3619902A1 (de) * 1986-06-13 1988-03-03 Biotechnolog Forschung Gmbh Cmv-dna-strukturen, expressionsvektor dafuer, cmv-proteinstrukturen und deren verwendung
ZA878031B (en) * 1986-11-04 1988-04-28 Scripps Clinic And Research Foundation Nucleic acid probes for the detection of latent human cytomegalovirus in blood products
EP0277773A1 (en) * 1987-01-30 1988-08-10 The Board Of Trustees Of The Leland Stanford Junior University Hybrid cytomegalovirus (CMV) and vaccine

Also Published As

Publication number Publication date
EP0389286A2 (en) 1990-09-26
GR3020765T3 (en) 1996-11-30
ATE140154T1 (de) 1996-07-15
CA2012895A1 (en) 1990-09-24
EP0389286B1 (en) 1996-07-10
EP0389286A3 (en) 1991-06-12
ES2091221T3 (es) 1996-11-01
DE69027695D1 (de) 1996-08-14
CA2012895C (en) 2000-01-18
DE69027695T2 (de) 1997-02-20

Similar Documents

Publication Publication Date Title
IT9020063A0 (it) Vaccino di poxvirus ricombinante di herpesvirus
ATE118353T1 (de) Rekombinanter herpes simplex gb-gd impfstoff.
FR2620459B1 (fr) Virus recombinant de la vaccine
FI903852A7 (fi) Menetelmä rekombinanttisen alayksikkörokotteen valmistamiseksi pseudor abiesinfektiota vastaan
BR8501924A (pt) Suporte ortodontico e suporte ortodontico de alumina cristalina
ATE120489T1 (de) Rekombinante coccidiosis-vakzine.
DK603888D0 (da) Rekombinant virus
IT1239987B (it) Sistema di selezione di spettro di infettivita' di poxvirus ricombinante
NZ517686A (en) Bovine vaccine formula comprising plasmid or plasmids containing gB and gD genes from the bovine herpesvirus
IT1205820B (it) Adiuvante immunologico per vaccini polisaccaridici
ATE140154T1 (de) Rekombinanter cytomegalovirus-impfstoff
DE3676873D1 (de) Glaskeramik fuer ringlaserkreisel.
ITMI913092A1 (it) Vaccino di poxvirus ricombinante del virus del morbillo
FI933495L (fi) Rekombinantadenovirusvacciner
EP0366238A3 (en) Influenza vaccinal polypeptides
EP0365646A4 (en) Synthetic peptides from streptococcal m protein and vaccines prepared therefrom
ES8800358A1 (es) Un procedimiento para preparar un polipeptido hibrido.
ATE189702T1 (de) Das für das pferde herpes-virus typ 1 glykoprotein d, kodierende gen, sein genprodukt, antikörper und ihre verwendung
DE3683001D1 (de) Verwendung von benzylsulfinylbenzimidazolen als zytoprotektive arzneimittel fuer den magendarmkanal.
AU7816987A (en) Expression of hepatitis B viral antigens from recombinant baculovirus vectors
KR900700509A (ko) 인간 거대세포 바이러스의 면역원성 당단백질
ES515472A0 (es) Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.
NO891691D0 (no) Rekombinant gag-forloeper for hiv.
IE863008L (en) "Viral Glycoprotein Subunit Vaccine"
NO903409D0 (no) Fremgangsmaate av en rekombinant subenhetsvaksine mot pseudorabies-infeksjon.